Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 4
2017 12
2018 16
2019 23
2020 19
2021 21
2022 18
2023 13
2024 2

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 36759200

101 results

Results by year

Filters applied: . Clear all
Page 1
68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning.
Calais J, Czernin J, Cao M, Kishan AU, Hegde JV, Shaverdian N, Sandler K, Chu FI, King CR, Steinberg ML, Rauscher I, Schmidt-Hegemann NS, Poeppel T, Hetkamp P, Ceci F, Herrmann K, Fendler WP, Eiber M, Nickols NG. Calais J, et al. J Nucl Med. 2018 Feb;59(2):230-237. doi: 10.2967/jnumed.117.201749. Epub 2017 Nov 9. J Nucl Med. 2018. PMID: 29123013 Free PMC article.
Prostate-specific membrane antigen positron emission tomography detected local failure after post-prostatectomy radiation therapy: Low rates of out-of-field recurrence validates current Australian prostate bed contouring guidelines.
Shakespeare TP, Yap SZL, Hsieh M, Tahir ARM, Armstrong S. Shakespeare TP, et al. J Med Imaging Radiat Oncol. 2023 Sep;67(6):662-667. doi: 10.1111/1754-9485.13556. Epub 2023 Jul 3. J Med Imaging Radiat Oncol. 2023. PMID: 37401187
Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy.
Rogowski P, Trapp C, von Bestenbostel R, Eze C, Ganswindt U, Li M, Unterrainer M, Zacherl MJ, Ilhan H, Beyer L, Kretschmer A, Bartenstein P, Stief C, Belka C, Schmidt-Hegemann NS. Rogowski P, et al. Eur J Nucl Med Mol Imaging. 2022 Mar;49(4):1417-1428. doi: 10.1007/s00259-021-05557-z. Epub 2021 Oct 10. Eur J Nucl Med Mol Imaging. 2022. PMID: 34628521 Free PMC article.
Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature.
Luiting HB, van Leeuwen PJ, Busstra MB, Brabander T, van der Poel HG, Donswijk ML, Vis AN, Emmett L, Stricker PD, Roobol MJ. Luiting HB, et al. BJU Int. 2020 Feb;125(2):206-214. doi: 10.1111/bju.14944. Epub 2019 Nov 29. BJU Int. 2020. PMID: 31680398 Free PMC article. Review.
Mapping of Local Recurrences After Radical Prostatectomy Using 68-Gallium-Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: Implications for Postprostatectomy Radiation Therapy Clinical Target Volumes.
Horsley PJ, Koo CM, Eade T, Hsiao E, Emmett L, Brown C, Kneebone A, Hruby G. Horsley PJ, et al. Int J Radiat Oncol Biol Phys. 2023 Jan 1;115(1):106-117. doi: 10.1016/j.ijrobp.2022.05.044. Epub 2022 Jun 15. Int J Radiat Oncol Biol Phys. 2023. PMID: 35716849
101 results